Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Our products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections.
In addition, we develop and manufacture a variety of biological and non-biological materials used in proficiency testing programs.
Closing share price
|Y, 2013||Y, 2014||Y, 2015||Y, 2016|
|$188.7 m||$188.8 m||$194.8 m||$196.1 m|
Revenue growth, %